We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Exhibits Brand-New All-in-One Molecular Diagnosis System at analytica Vietnam 2023

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, is attending analytica Vietnam 2023, marking the first time Tianlong is exhibiting in Vietnam.

The 7th analytica Vietnam 2023 is taking place from April 19-21, 2023, at the Saigon Exhibition and Convention Center in Ho Chi Minh City, Vietnam. Recognized as the most crucial hub in the ASEAN Region, analytica Vietnam is celebrating its largest event to date, expecting 5,000 diagnostic professionals, top industry buyers, and investment decision-makers from over 30 countries worldwide.

At analytica Vietnam 2023, Tianlong is showcasing its brand-new all-in-one molecular diagnosis system Panall 8000, alongside its latest offerings in PCR laboratory diagnostics. Earlier, Tianlong had launched the Panall 8000 All-in-one Molecular Diagnosis System at Medlab Middle East 2023 where the new product had attracted significant attention.

The innovative lab booster, Tianlong Panall 8000, is a user-friendly and secure molecular diagnosis system that combines the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis. This system enables a truly seamless sample in-result out detection process and offers immense convenience for professionals through a one-key operation.

Alongside the Panall 8000, Tianlong is also presenting its innovative PCR lab solutions, including nucleic acid extractors, real-time PCR systems, sample processing systems, liquid handling systems, and compatible reagents, at analytica Vietnam 2023.

Related Links:
Tianlong Science and Technology

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.